Recent Price Movements and Market Comparison
Godavari Drugs has been under pressure over the past week, with its stock falling by 8.23%, contrasting sharply with the Sensex’s modest gain of 0.79% during the same period. This divergence highlights the stock’s relative weakness within the broader market context. Over the year-to-date period, the stock has declined by 29.34%, while the Sensex has advanced by 9.08%, further emphasising the stock’s underperformance. The one-year return paints a similar picture, with Godavari Drugs down 31.86% against the Sensex’s 10.47% gain.
Despite a longer-term five-year gain of 130.31%, which outpaces the Sensex’s 94.23% rise, the recent trend indicates a loss of momentum. The stock’s three-year return of 17.25% also lags behind the ben...
Read More













